Invention Grant
- Patent Title: Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signaling
-
Application No.: US17091526Application Date: 2020-11-06
-
Publication No.: US11725055B2Publication Date: 2023-08-15
- Inventor: Angeles Estelles , Mikhail Gishizky , Stefan Ryser , Lawrence M. Kauvar
- Applicant: Trellis Bioscience, LLC
- Applicant Address: US CA Redwood City
- Assignee: Trellis Bioscience, LLC
- Current Assignee: Trellis Bioscience, LLC
- Current Assignee Address: US CA Redwood City
- Agency: FisherBroyles, LLP
- Agent Jason M. Pass
- The original application number of the division: US15619327 2017.06.09
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K45/06
Abstract:
Monoclonal antibodies derived from the native human repertoire that bind the extracellular portion of Killer IgG Receptor (KIR) and pharmaceutical and veterinary compositions thereof are useful in treating cancer in human and other subjects.
Public/Granted literature
- US20210054075A1 MONOCLONAL ANTIBODIES TARGETING KILLER IMMUNOGLOBULIN-LIKE RECEPTOR (KIR) FAMILY SIGNALING Public/Granted day:2021-02-25
Information query
